CN111018772A - 一类具有抗肿瘤活性的5-磺酰胺基取代的靛红类衍生物 - Google Patents
一类具有抗肿瘤活性的5-磺酰胺基取代的靛红类衍生物 Download PDFInfo
- Publication number
- CN111018772A CN111018772A CN201911152031.8A CN201911152031A CN111018772A CN 111018772 A CN111018772 A CN 111018772A CN 201911152031 A CN201911152031 A CN 201911152031A CN 111018772 A CN111018772 A CN 111018772A
- Authority
- CN
- China
- Prior art keywords
- novel
- isatin
- sulfonamide
- sulfonamide substituted
- substituted isatin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/38—Oxygen atoms in positions 2 and 3, e.g. isatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911152031.8A CN111018772A (zh) | 2019-11-21 | 2019-11-21 | 一类具有抗肿瘤活性的5-磺酰胺基取代的靛红类衍生物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911152031.8A CN111018772A (zh) | 2019-11-21 | 2019-11-21 | 一类具有抗肿瘤活性的5-磺酰胺基取代的靛红类衍生物 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111018772A true CN111018772A (zh) | 2020-04-17 |
Family
ID=70206350
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911152031.8A Pending CN111018772A (zh) | 2019-11-21 | 2019-11-21 | 一类具有抗肿瘤活性的5-磺酰胺基取代的靛红类衍生物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111018772A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111018871A (zh) * | 2019-12-30 | 2020-04-17 | 天津科技大学 | 一类具有抗肿瘤活性的5-酰胺基取代的靛红类衍生物 |
CN116496292A (zh) * | 2023-03-30 | 2023-07-28 | 天津科技大学 | 一种苯磺酰胺类衍生物及其制备方法和应用 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008074078A1 (en) * | 2006-12-19 | 2008-06-26 | University Of Wollongong | Selectively deliverable isatin-based cytotoxic agents |
CN101863823A (zh) * | 2010-06-03 | 2010-10-20 | 山东大学 | 吲哚二酮类化合物及其扩环衍生物、制备方法及应用 |
CN104130175A (zh) * | 2014-06-13 | 2014-11-05 | 天津科技大学 | 不同位置取代吲哚酮类衍生物及其应用 |
US20160304533A1 (en) * | 2015-04-20 | 2016-10-20 | Phusis Therapeutics, Inc. | Compounds, compositions and methods for inhibiting cnksr1 |
WO2018109650A1 (en) * | 2016-12-14 | 2018-06-21 | Aurigene Discovery Technologies Limited | Spiro[cyclopentane-1,3'-indolin]-2'-one derivatives as bromodomain inhibitors |
-
2019
- 2019-11-21 CN CN201911152031.8A patent/CN111018772A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008074078A1 (en) * | 2006-12-19 | 2008-06-26 | University Of Wollongong | Selectively deliverable isatin-based cytotoxic agents |
CN101863823A (zh) * | 2010-06-03 | 2010-10-20 | 山东大学 | 吲哚二酮类化合物及其扩环衍生物、制备方法及应用 |
CN104130175A (zh) * | 2014-06-13 | 2014-11-05 | 天津科技大学 | 不同位置取代吲哚酮类衍生物及其应用 |
US20160304533A1 (en) * | 2015-04-20 | 2016-10-20 | Phusis Therapeutics, Inc. | Compounds, compositions and methods for inhibiting cnksr1 |
WO2018109650A1 (en) * | 2016-12-14 | 2018-06-21 | Aurigene Discovery Technologies Limited | Spiro[cyclopentane-1,3'-indolin]-2'-one derivatives as bromodomain inhibitors |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111018871A (zh) * | 2019-12-30 | 2020-04-17 | 天津科技大学 | 一类具有抗肿瘤活性的5-酰胺基取代的靛红类衍生物 |
CN116496292A (zh) * | 2023-03-30 | 2023-07-28 | 天津科技大学 | 一种苯磺酰胺类衍生物及其制备方法和应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109438365B (zh) | N-(3-((4-三氟甲基)-2-嘧啶基)氨基苯基)-2,6-二氟苯磺酰胺衍生物 | |
CN109232477B (zh) | 查尔酮-氨基二硫代甲酸酯类过氧化氢酶抑制剂及其合成方法和应用 | |
CN109293657B (zh) | 一种α-咔啉酮类化合物及其制备方法和应用 | |
CN113045399B (zh) | 查尔酮衍生物及其用途 | |
CN111018772A (zh) | 一类具有抗肿瘤活性的5-磺酰胺基取代的靛红类衍生物 | |
CN111646941A (zh) | 一种磺酰胺类衍生物及其制备方法和应用 | |
CN112047880B (zh) | 一类氮杂黄酮衍生物及其作为抗肿瘤药物的应用 | |
CN108299398B (zh) | 一种具有抗肿瘤活性含咔唑的喹唑啉衍生物及其制药用途 | |
Huang et al. | Synthesis, characterization and antitumor activity of novel amide derivatives containing ferrocenyl pyrazol-moiety | |
CN109516926B (zh) | 一种荜茇明碱衍生物制备及用途 | |
CN111635449A (zh) | 一种羽扇豆醇吡啶季铵盐衍生物及其制备方法与应用 | |
CN110437156A (zh) | 丹皮酚二氢嘧啶酮类衍生物及其制备方法和应用 | |
CN109232703A (zh) | 含16-(1′-芳香基-1′,2′,3′-三氮唑)亚甲基-雄甾-17-酮衍生物 | |
CN112480129B (zh) | 一种含胍基结构单元的多环螺吲哚啉化合物及其制备方法和应用 | |
CN111018871A (zh) | 一类具有抗肿瘤活性的5-酰胺基取代的靛红类衍生物 | |
CN108690038B (zh) | 一种香豆雌酚衍生物及制备方法和应用 | |
CN106083884A (zh) | 一种d‑亮氨酸取代去甲斑蝥素衍生物及其制备方法与应用 | |
CN105884670B (zh) | 一类2,3,4-三取代吡咯类化合物及其合成方法和应用 | |
CN111333495A (zh) | (4-甲氧基-3-羟基苯基)(3,5-二甲基-2-羟基苯基)甲酮及制备方法和应用 | |
CN111170940B (zh) | 一种1,4-二氢喹啉以及1,4-二氢吡啶类化合物的合成方法及其在抗肿瘤药物中的应用 | |
CN115073547B (zh) | 一种甾体咔啉衍生物及其制备方法和应用、抗肿瘤药物组合物 | |
CN106188081B (zh) | 一种d-缬氨酸取代去甲斑蝥素衍生物及其制备方法与应用 | |
CN114933599B (zh) | 一种双β-咔啉类化合物及其药用盐、制备方法和应用 | |
CN110128342A (zh) | 一类具有抗肿瘤活性的3,5-二苯基取代的二氢吡唑类衍生物及合成方法和应用 | |
WO2021244555A1 (zh) | 一种手性中间体及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Yu Peng Inventor after: Cheng Yan Inventor after: Cui Panpan Inventor after: Sun Rui Inventor after: Zhao Lianbo Inventor after: Hao Lei Inventor after: Wang Dong Inventor after: Teng Yuou Inventor before: Yu Peng Inventor before: Cheng Yan Inventor before: Cui Shanshan Inventor before: Sun Rui Inventor before: Zhao Lianbo Inventor before: Hao Lei Inventor before: Wang Dong Inventor before: Teng Yuou |
|
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200417 |